| 津普森 |
300265-50mg |
50mg |
现货 |
301305-73-7 |
2-(3,4-二甲氧基苯甲酰胺基)-4,5,6,7-四氢... |
98+% |
562.44
562.44
|
|
| 津普森 |
300265-100mg |
100mg |
现货 |
301305-73-7 |
2-(3,4-二甲氧基苯甲酰胺基)-4,5,6,7-四氢... |
98+% |
954.00
954.00
|
|
| 津普森 |
300265-250mg |
250mg |
现货 |
301305-73-7 |
2-(3,4-二甲氧基苯甲酰胺基)-4,5,6,7-四氢... |
98+% |
1,621.68
1,621.68
|
|
| 津普森 |
I026013-25mg |
25mg |
现货 |
301305-73-7 |
2-(3,4-二甲氧基苯甲酰胺基)-4,5,6,7-四氢... |
99% |
439.20
439.20
|
|
| 罗恩 |
R026013-50mg |
50mg |
5~7个工作日 |
301305-73-7 |
2-(3,4-二甲氧基苯甲酰胺基)-4,5,6,7-四氢... 2-(3,4-Dimethoxybenzamido)-... |
99% |
785.00
785.00
|
|
| 罗恩 |
R026013-25mg |
25mg |
现货 |
301305-73-7 |
2-(3,4-二甲氧基苯甲酰胺基)-4,5,6,7-四氢... 2-(3,4-Dimethoxybenzamido)-... |
99% |
610.00
610.00
|
|
| Selleck |
S802310mg |
10mg |
现货 |
301305-73-7 |
TCS 359 |
|
1,205.32
1,205.32
|
|
| Selleck |
S802350mg |
50mg |
现货 |
301305-73-7 |
TCS 359 |
|
3,848.43
3,848.43
|
|
| 毕得 |
BD298133-10mg |
10mg |
现货 |
301305-73-7 |
2-(3,4-二甲氧基苯甲酰胺基)-4,5,6,7-四氢... 2-(3,4-Dimethoxybenzamido)-4... |
98+% |
545.00
545.00
|
|
| 毕得 |
BD298133-50mg |
50mg |
现货 |
301305-73-7 |
2-(3,4-二甲氧基苯甲酰胺基)-4,5,6,7-四氢... 2-(3,4-Dimethoxybenzamido)-4... |
98+% |
654.00
654.00
|
|
| 阿拉丁 |
T129806-10mg |
10mg |
现货 |
301305-73-7 |
TCS 359,有效的FLT3受体酪氨酸激酶抑制剂 TCS 359 |
Moligand™, ≥99% |
330.90
330.90
|
|
| 阿拉丁 |
T129806-50mg |
50mg |
现货 |
301305-73-7 |
TCS 359,有效的FLT3受体酪氨酸激酶抑制剂 TCS 359 |
Moligand™, ≥99% |
654.90
654.90
|
|
| 阿拉丁 |
T129806-25mg |
25mg |
现货 |
301305-73-7 |
TCS 359,有效的FLT3受体酪氨酸激酶抑制剂 TCS 359 |
Moligand™, ≥99% |
490.90
490.90
|
|
| 阿拉丁 |
T129806-100mg |
100mg |
期货,请咨询 |
301305-73-7 |
TCS 359,有效的FLT3受体酪氨酸激酶抑制剂 TCS 359 |
Moligand™, ≥99% |
1,111.90
1,111.90
|
|
| TM |
716405-10mg |
10mg |
现货 |
301305-73-7 |
标准品/2-(3,4-二甲氧基苯甲酰胺基)-4,5,6,... |
≥98.0% |
1,470.00
1,470.00
|
|
| 梯希爱 |
D5275-25MG |
25MG |
现货 |
301305-73-7 |
TCS 359 TCS 359 |
98.0% |
560.00
560.00
|
|
| 梯希爱 |
D5275-100MG |
100MG |
现货 |
301305-73-7 |
TCS 359 TCS 359 |
98.0% |
1,790.00
1,790.00
|
|